Abivax is advancing obefazimod, a first-in-class oral therapy for UC and CD, with major upcoming data catalysts. Click here ...

Vishnu Kiritee Guttikonda ’26, a student in the Master of Advanced Management program, toured pharmaceutical and ...

HONG KONG, March 27, 2026 /PRNewswire/ -- Unisound (09678.HK) announced its audited annual results for the year ended December 31, 2025. As the Company's first annual results announcement since ...

ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 patients annually in ...

From a governance and leadership standpoint, Brendan and I will continue in our current roles, ensuring continuity of strategy and execution. McCormick will remain globally headquartered in Hunt ...

Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 ...

In the topsy-turvy world of aviation, Willie Walsh, the sharpshooting incoming CEO of IndiGo, has a rather peculiar nickname: ...

McCormick & Company, Incorporated (NYSE:MKC) Q1 2026 Earnings Call Transcript March 31, 2026 McCormick & Company, Incorporated beats earnings expectations. Reported EPS is $0.66, expectations were $0.

MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") recently ...

Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its ...

Timothy Archer is one of the most technically accomplished and strategically astute executives in the global semiconductor equipment industry, widely recognized for his deep expertise in thin-film ...